News & Analysis as of

Merger Controls Investment Investors

A&O Shearman

Navigating German FDI Rules

A&O Shearman on

KEY CONSIDERATIONS AND PRACTICAL INSIGHTS FOR VENTURE CAPITAL INVESTORS - Germany’s foreign direct investment (FDI) regime has been expanded considerably in recent years, mirroring a global trend towards increased scrutiny...more

A&O Shearman

Strategic steer and CMA policy proposals: UK government consults on its steer to the CMA

A&O Shearman on

Searching for ways to achieve its promised ‘growth’ and productivity ambitions, the UK government turned its gaze on the UK regulators around October last year, with the UK prime minister promising to “rip up the bureaucracy...more

Skadden, Arps, Slate, Meagher & Flom LLP

CMA’s Growth Agenda: UK Competition Authority May Loosen Position on Merger Remedies

The United Kingdom’s Competition and Markets Authority (CMA) will, in the new year, launch a review of its approach to merger remedies which could lead to a shift away from its long-standing preference for structural...more

White & Case LLP

Made in Italy: Big deals, PE, TMT and consumer sectors boost Italian M&A deal value in 2024

White & Case LLP on

The current Italian macroeconomic picture is somewhat mixed. While the International Monetary Fund forecast Italy’s target GDP growth at 0.7 percent, just under Western Europe’s 0.9 percent, Italy’s economy minister Giancarlo...more

Orrick, Herrington & Sutcliffe LLP

Founder Series: Managing Investment Control Risk in the UK

Orrick's Founder Series offers monthly top tips for UK startups on key considerations at each stage of their lifecycle, from incorporating a company through to possible exit strategies. The Series is written by members of our...more

Polsinelli

California’s AB 3129 Continues National Trend of Scrutinizing Private Equity Investments in the Health Care Industry

Polsinelli on

The California legislature is considering a bill that could severely impact the ability for private equity companies and hedge funds to operate in the California health care industry. AB 3129, introduced by Assembly Member...more

A&O Shearman

Global business in a changing Europe - 2024

A&O Shearman on

With Parliamentary elections and a series of national votes in 2024, the EU is entering a pivotal period in its history. In this study, ‘Global business in a changing Europe’, we speak to corporate leaders across the world to...more

Akin Gump Strauss Hauer & Feld LLP

The Road Ahead for Private Equity: Antitrust and Merger Control

Recent actions by antitrust agencies globally deliver on their promises for increased scrutiny of private equity sponsored transactions and strategies in at least three ways....more

Paul Hastings LLP

Minority Stakes — Beware of UK National Security Risks

Paul Hastings LLP on

The U.K. Government’s recent conditional approval of a minority investment (coupled with a commercial arrangement) by Emirates Telecommunications Group Co. PJSC (“e&”) (majority owned by the UAE Government) over Vodafone...more

A&O Shearman

Antitrust scrutiny of private equity deals intensifies

A&O Shearman on

Traditionally, private equity firms were seen as benign investors from an antitrust perspective. This is changing. In the past 12 months, PE-funded acquisitions have faced progressively more rigorous scrutiny by antitrust...more

Stikeman Elliott LLP

Increased Investment Canada Act Review Thresholds Announced for 2024

Stikeman Elliott LLP on

The Canadian government has increased the monetary thresholds to determine whether a net benefit review of a foreign investment in Canada is required under the Investment Canada Act for 2024. All acquisitions of control of...more

Skadden, Arps, Slate, Meagher & Flom LLP

The Informed Board - Fall 2023

Boards routinely confront an array of difficult issues. In this issue of The Informed Board, we tackle four of the thorniest and most topical: - How to preserve the integrity of a deal process where a key fiduciary (say,...more

Skadden, Arps, Slate, Meagher & Flom LLP

UK Public M&A Update – H2 2022

2022 vs. 2021 Public M&A activity in the UK in 2022 returned to moderate levels after a busy 2021. The 28 firm offers announced in H1 2022 was in line with H1 2021, demonstrating a steady trajectory back towards pre-pandemic...more

McDermott Will & Emery

International: Investing in Global Healthcare and Life Sciences - A guide to key legal and regulatory issues in health and life...

Today’s global healthcare marketplace is marked by unprecedented transformation. This presents both challenges and opportunity to today’s market participants. We know how important it is to structure cross-border investments...more

Stikeman Elliott LLP

Merger Control 2022

Stikeman Elliott LLP on

1. Relevant Authorities and Legislation - 1.1. Who is/are the relevant merger authority(ies)? The Competition Bureau (the “Bureau”) is an independent, federal law enforcement agency responsible for the administration...more

McDermott Will & Emery

Affaire Illumina / Grail : La Commission européenne Dit « Pause ! »

McDermott Will & Emery on

Le 29 octobre 2021, la Commission européenne (« Commission ») a adopté des mesures provisoires dans le cadre d’une enquête de gun-jumping afin d’éviter la réalisation anticipée de l’acquisition de la société américaine Grail...more

White & Case LLP

Italian M&A on track to reach post-crisis high

White & Case LLP on

An increase in megadeals reveals growing dealmaker appetite within Italy’s M&A market - Dealmaking confidence appears to be returning within the Italian M&A market. A total of US$57.4 billion-worth of deals announced in...more

Orrick, Herrington & Sutcliffe LLP

Corporate Venture Capital 2017 - Structures, Challenges, Success Factors

In a time of ever-shorter innovation cycles and the increased digitalization of many value-added chains, established businesses need to constantly evolve and reinvent themselves – even going so far as to rethink their core...more

Orrick, Herrington & Sutcliffe LLP

Corporate Venture Capital 2017 - Strukturen, Herausforderungen, Erfolgsfaktoren

In a time of ever-shorter innovation cycles and the increased digitalization of many value-added chains, established businesses need to constantly evolve and reinvent themselves – even going so far as to rethink their core...more

19 Results
 / 
View per page
Page: of 1

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
- hide
- hide